CN1271608A - Health-care enzymatic chitosan food - Google Patents
Health-care enzymatic chitosan food Download PDFInfo
- Publication number
- CN1271608A CN1271608A CN 99105991 CN99105991A CN1271608A CN 1271608 A CN1271608 A CN 1271608A CN 99105991 CN99105991 CN 99105991 CN 99105991 A CN99105991 A CN 99105991A CN 1271608 A CN1271608 A CN 1271608A
- Authority
- CN
- China
- Prior art keywords
- grams
- vitamin
- enzyme
- chitosan
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 40
- 230000002255 enzymatic effect Effects 0.000 title abstract description 3
- 108090000790 Enzymes Proteins 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 15
- 229920002101 Chitin Polymers 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 239000011573 trace mineral Substances 0.000 claims abstract description 8
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 8
- 150000002894 organic compounds Chemical class 0.000 claims abstract description 7
- 229940088598 enzyme Drugs 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 235000001014 amino acid Nutrition 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000004365 Protease Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- -1 L-Asnase Proteins 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 4
- 102000013142 Amylases Human genes 0.000 claims description 4
- 108010065511 Amylases Proteins 0.000 claims description 4
- 108010004032 Bromelains Proteins 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 102000016943 Muramidase Human genes 0.000 claims description 4
- 108010014251 Muramidase Proteins 0.000 claims description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 4
- 108090000526 Papain Proteins 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 235000019418 amylase Nutrition 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 229910052732 germanium Inorganic materials 0.000 claims description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 4
- 229960000274 lysozyme Drugs 0.000 claims description 4
- 235000010335 lysozyme Nutrition 0.000 claims description 4
- 239000004325 lysozyme Substances 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 101710151480 Chitinase 8 Proteins 0.000 claims description 2
- 102000012286 Chitinases Human genes 0.000 claims description 2
- 108010022172 Chitinases Proteins 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 102000019265 Cytochrome c1 Human genes 0.000 claims description 2
- 108010052832 Cytochromes Proteins 0.000 claims description 2
- 102000018832 Cytochromes Human genes 0.000 claims description 2
- 108010007528 Cytochromes c1 Proteins 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- DOBFQAFZFTURAD-RGMNGODLSA-N [Cu].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Cu].C(CC)N[C@@H](CCO)C(=O)O DOBFQAFZFTURAD-RGMNGODLSA-N 0.000 claims description 2
- GIDJXAQRKDSAND-UHFFFAOYSA-J [Ge+4].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O Chemical compound [Ge+4].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O GIDJXAQRKDSAND-UHFFFAOYSA-J 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 2
- 235000003969 glutathione Nutrition 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- ZPEJZWGMHAKWNL-UHFFFAOYSA-L zinc;oxalate Chemical compound [Zn+2].[O-]C(=O)C([O-])=O ZPEJZWGMHAKWNL-UHFFFAOYSA-L 0.000 claims description 2
- 230000001093 anti-cancer Effects 0.000 abstract description 6
- 230000007180 physiological regulation Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 7
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 150000002482 oligosaccharides Chemical class 0.000 description 6
- 241000371997 Eriocheir sinensis Species 0.000 description 3
- 241000238040 Panulirus Species 0.000 description 3
- 241000927735 Penaeus Species 0.000 description 3
- 230000006196 deacetylation Effects 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 230000003544 deproteinization Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 239000002839 antibiotic anticancer agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Abstract
A health-care enzymatic chitosan food contains chitosan (50-70 wt. portions), chitin (5-7), enzyme (15-25), organic compound containing trace elements (0-5), vitamines (5-10) and amino acids (5-10), and can play the role of improving physiologic regulation, raising immunity, and increasing anticancer activity.
Description
The present invention relates to health product, refer in particular to a kind of enzyme-added chitosan health product.
Development along with biotechnology; people successfully make the chitosan of solubility with living marine resources Carapax Eriocheir sinensis or Crusta Penaeus seu Panulirus etc.; it has the effect that improves immune function of human body, regulates body fluid acid-base balance and protection skin; the fit oligosaccharide of low molecular weight polycaprolactone that experimental results show that its six glucamine has preferable physiological regulation function and active anticancer; but; the content of oligosaccharide is very low in general chitosan, makes the technology more complicated of oligosaccharide separately, and price is also very expensive.
The inventor creates technical scheme of the present invention through secular experiment and research.
The object of the present invention is to provide a kind of enzyme-added chitosan health product, join in the chitosan by enzyme proper proportion, produce the oligosaccharide of required ratio, cooperate the effect of trace element and vitamin to reach the physiological regulation ability that strengthens again, increase the purpose of immunologic function and enhancing active anticancer.
The object of the present invention is achieved like this: a kind of enzyme-added chitosan health product is characterized in that
Form (parts by weight) by following composition and proportioning: chitosan 50-70, chitin 5-7, enzyme 15-25, the organic compound 0-5 that contains trace element, vitamin 5-10, aminoacid 5-10.
Described enzyme comprises at least a of following composition: surpass oxide dismutase, lysozyme, papain, bromelain, amylase, pepsin, trypsin, chitinase, L-Asnase, Cytochrome C, glutathion peroxidase.
The described organic compound that contains trace element comprises in the organic compound that contains following element at least a: ferrum, copper, zinc, selenium, germanium, calcium, magnesium.
Described vitamin comprises in vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, the compound vitamin at least a.
Major advantage of the present invention is:
1, because after adding enzyme in the chitosan, in the process of taking, can decompose the generation oligosaccharide to chitosan, cooperate the effect of enzyme and trace element and vitamin again, can increase the physiological regulation ability greatly, raise immunity and anticancer activity, the speed of advancing to react with enzymatic can accelerate 10 after tested
5-10
20Doubly, and the catalytic action of enzyme also has mildness and specificity, do not need heating, and particularly the compound enzyme that forms with plurality of enzymes has better synergism.
2, health product of the present invention have aid digestion, as to increase appetite and building body health-care effect, are specially adapted to the prolonged illness weakness, operation back or postpartum recovery, the slow or weakling's of old metabolic function health product.
3, health product of the present invention also have significant antibiotic anticancer function, can alleviate the misery of cancer patient, the pathogenic bacteria encirclement of invading can be decomposed or engulf, and strengthen competent cell, the molten sick cell that disappears, or its decomposition is excreted, and promote that the circulation of blood is unimpeded.
The present invention is further described below in conjunction with preferred embodiment.
Embodiment 1
Enzyme-added chitosan health product of the present invention are made up of following composition and proportioning: chitosan 55 restrains, chitin 5.5 restrains, surpasses oxide dismutase 10 grams, chitinase 8 restrains,
Propylhomoserin copper 1 gram, vitamin C 6 grams, aminoacids complex 6 grams.
Its manufacture method is that marine organisms Carapax Eriocheir sinensis or Crusta Penaeus seu Panulirus are carried out decalcification, deproteinization, defat fat and depigmentation processing according to conventional method; further carrying out deacetylation again handles; make deacetylation and reach chitosan more than 90%; again through refining purification, drying, pulverizing; other commercially available medical grade raw material of reuse mixes in proportion, pulverizes, crosses the 40-80 mesh sieve; the powder system of making or capsule, sterilization packaging.
Embodiment 2
Enzyme-added chitosan health product of the present invention are made up of following composition and proportioning:
Chitosan 60 grams, chitin 6 grams, lysozyme 8 grams, papain 14 grams, Cytochrome C 1 gram, inositol unit phosphate ester calcium magnesium salt 1 gram, Germanium tetraacetate. 1 gram, compound vitamin 8 grams, aminoacids complex 7 grams.
Its manufacture method is with embodiment 1, so do not repeat.
Embodiment 3
Enzyme-added chitosan health product of the present invention are made up of following composition and proportioning:
Chitosan 58 grams, chitin 5.7 grams, compound enzyme 15 grams, L-Asnase 5 grams, organic selenium 1 gram, zinc oxalate 0.5 gram, vitamin A+D13 gram, aminoacids complex 5 grams.
Embodiment 4
Enzyme-added chitosan health product of the present invention are made up of following composition and proportioning: chitosan 59 grams, chitin 6.7 grams, bromelain 10 grams, amylase 3 grams, organic germanium 2 grams, organic selenium 1 gram, vitamin B
1B
28 grams, aminoacids complex 5 grams.
Embodiment 5
The effect of enzyme-added chitosan health product of the present invention.
Chitosan of the present invention is made the chitosan of solubility again for to make chitin from halobiontic Carapax Eriocheir sinensis or Crusta Penaeus seu Panulirus etc. through decalcification, deproteinization, defat fat and the depigmentation through deacetylation, its reaction equation is:
The chitin chitosan is n＜500 wherein
Chitosan wherein under the effect of enzyme further partial hydrolysis fit this oligosaccharide of oligochitosan of low molecular weight polycaprolactone of becoming to have six glucamine cooperate enzyme and trace element and vitamin synergism, more can increase the physiological regulation ability greatly, increase immunologic function and active anticancer, produce fabulous health invigorating and the anticancer effect of sterilization.Usual amounts every day 1-3 time, each 1-2 gram, 15 days is a course of treatment, enters for second course of treatment again in drug withdrawal 3-5 days.Practical function sees Table 1.
Table 1
| Name | Disease | The course of treatment number | Effect |
| Mr. Zhang | Hepatocarcinoma mid-term, become thin, liver is painful | ????6 | Stimulating appetite, pain relief, spirit take a turn for the better |
| Mr. Sun | Rectal cancer | ????6 | Disease alleviates |
| Mrs Zhou | Climacteric syndrome, body void, unable | ????3 | Asymptomatic |
| Mrs Xia | Cholecystitis | ????4 | Transference cure |
| Mr. Tong | Hyperlipidemia 350 | ????5 | Recover normal |
| Mrs Zhao | The cardiovascular and cerebrovascular vessel blood supply insufficiency | ????3 | Recovery from illness |
| Mr. Wang | Diabetes, glucose in urine +++ | ????8 | Glucose in urine+ |
| Miss Li | Facial black speck | ????5 | Recovery from illness |
Claims (8)
1, a kind of enzyme-added chitosan health product is characterized in that forming (parts by weight) by following composition and proportioning: chitosan 50-70, chitin 5-7, enzyme 15-25, the organic compound 0-5 that contains trace element, vitamin 5-10, aminoacid 5-10.
2, as the described enzyme-added chitosan health product of claim l, it is characterized in that described enzyme comprises at least a of following composition: surpass oxide dismutase, lysozyme, papain, bromelain, amylase, pepsin, trypsin, chitinase, L-Asnase, Cytochrome C, glutathion peroxidase.
3, enzyme-added chitosan health product as claimed in claim 1 is characterized in that the described organic compound that contains trace element comprises in the organic compound that contains following element at least a: ferrum, copper, zinc, selenium, germanium, calcium, magnesium.
4, enzyme-added chitosan health product as claimed in claim 1, it is at least a to it is characterized in that described vitamin comprises in vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, the compound vitamin.
5, the doubtful sugared health product of enzyme-added shell as claimed in claim 1 is characterized in that being made up of following composition and proportioning: chitosan 55 restrains, chitin 5.5 restrains, surpasses oxide dismutase 10 grams, chitinase 8 restrains,
Propylhomoserin copper 1 gram, vitamin C 6 grams, aminoacids complex 6 grams.
6, enzyme-added chitosan health product as claimed in claim 1 is characterized in that being made up of following composition and proportioning: chitosan 60 grams, chitin 6 grams, lysozyme 8 grams, papain 14 grams, Cytochrome C 1 gram, inositol unit phosphate ester calcium magnesium salt 1 gram, Germanium tetraacetate. 1 gram, compound vitamin 8 grams, aminoacids complex 7 grams.
7, enzyme-added chitosan health product as claimed in claim 1 is characterized in that being made up of following composition and proportioning: chitosan 58 grams, chitin 5.7 grams, compound enzyme 15 grams, L-Asnase 5 grams, organic selenium 1 gram, zinc oxalate 0.5 gram, vitamin A+D13 gram, aminoacids complex 5 grams.
8, enzyme-added chitosan health product as claimed in claim 1 is characterized in that being made up of following composition and proportioning: chitosan 59 grams, chitin 6.7 grams, bromelain 10 grams, amylase 3 grams, organic germanium 2 grams, organic selenium 1 gram, vitamin B
1B
28 grams, aminoacids complex 5 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99105991 CN1100567C (en) | 1999-04-27 | 1999-04-27 | Health-care enzymatic chitosan food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99105991 CN1100567C (en) | 1999-04-27 | 1999-04-27 | Health-care enzymatic chitosan food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1271608A true CN1271608A (en) | 2000-11-01 |
| CN1100567C CN1100567C (en) | 2003-02-05 |
Family
ID=5272207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99105991 Expired - Lifetime CN1100567C (en) | 1999-04-27 | 1999-04-27 | Health-care enzymatic chitosan food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1100567C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101519112B (en) * | 2009-04-17 | 2011-04-20 | 无锡市鸿声船用玻璃钢有限公司 | High-speed working and rescue boat under high sea conditions |
| CN103431392A (en) * | 2013-08-29 | 2013-12-11 | 青岛海百合生物技术有限公司 | Composite marine food for special dietary uses for diabetics |
-
1999
- 1999-04-27 CN CN 99105991 patent/CN1100567C/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101519112B (en) * | 2009-04-17 | 2011-04-20 | 无锡市鸿声船用玻璃钢有限公司 | High-speed working and rescue boat under high sea conditions |
| CN103431392A (en) * | 2013-08-29 | 2013-12-11 | 青岛海百合生物技术有限公司 | Composite marine food for special dietary uses for diabetics |
| CN103431392B (en) * | 2013-08-29 | 2014-12-17 | 青岛海百合生物技术有限公司 | Composite marine food for special dietary uses for diabetics |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1100567C (en) | 2003-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1264521C (en) | Nano selenium of chitin and its preparation method | |
| CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
| CN105287649A (en) | Medical probiotics capsule | |
| CN103005255A (en) | Chitosan oligosaccharide-collagen peptide compound health food and preparation method thereof | |
| CN103404765B (en) | Composite marine special dietary food for consumption of tumor patients | |
| CN101574132B (en) | Mung bean yoghourt product having function of reducing blood pressure and preparation method thereof | |
| CN117357634A (en) | Protein injection and preparation method thereof | |
| CN1100567C (en) | Health-care enzymatic chitosan food | |
| CN105613882A (en) | Black barley hypoglycemic tea (milky tea) | |
| CN101474236A (en) | Ganoderma lucidum wall-broken spore powder capsule | |
| CN111567758A (en) | Shark cartilage powder substitute and preparation method thereof | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN1864545A (en) | Preparation of highland barley SOD an conditioning food containing highland barley SOD | |
| JP2004269407A (en) | Constipation ameliorant and food and beverage containing the same | |
| CN114617267A (en) | Reinforced composite bone peptide and preparation method and application thereof | |
| TW202205973A (en) | Jelly food composition can effectively combine the fish collagen and the dietary fiber | |
| CN1423961A (en) | Chitin healthy food and production thereof | |
| CN107712587A (en) | A kind of anti-oxidant anti-aging nutrient powder and preparation method thereof | |
| CN115005447B (en) | Application of oligoguluronic acid in preparation of anti-fatigue product | |
| CN115590896B (en) | Application of low molecular dextran bezoar acid and chlorella in preparing medicine for treating skin related diseases | |
| CN1895293A (en) | Spirulina oral tablet for supplementing human-body nutrients and its preparation | |
| CN1415309A (en) | Nano selenium of Melatonin and its preparation method | |
| KR102517928B1 (en) | Injection composition comprising hyaluronidase for removing local fat | |
| KR102107947B1 (en) | health supplement beverage | |
| WO2002028400A1 (en) | A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Chen Jiayan Document name: Qualified notice of first instance |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Chen Jiayan Document name: Notification to Pay the Fees |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20030205 |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Chen Jiayan Document name: Notification of Expiration of Patent Right Duration |